what are the glp-1 medications Understanding GLP-1 Drugs from the Gray

PMC12346945

medRxiv, 10.1101/2025.07.05.253309332025.07.05.25330933[AQ, 2025, preprint: not peer reviewed

More than half of workers (51%) believe GLP-1 coverage should be a standard health benefit, signaling a clear shift in what people consider essential workplace support

As a community pharmacist and pharmacy owner, I see this as both a challenge and an opportunity: Patients will finally gain affordable access improving adherence and equity

Interestingly, taVNS has documented efficacy in depression, which may represent an additional benefit for psychiatric patients (132)

That's true for both the shot and pill